Are you Dr. Ilani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
520 N Prospect Ave
Suite 103
Redondo Beach, CA 90277Phone+1 310-376-8816Fax+1 310-374-2806
Summary
- Dr. Niloufar Ilani, MD is an endocrinologist in Redondo Beach, California. She is currently licensed to practice medicine in California. She is affiliated with Providence Little Company of Mary Medical Center - Torrance, Torrance Memorial Medical Center, and Providence Saint John's Health Center.
Education & Training
- Los Angeles County-Harbor-UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2011
- Charles R Drew University of Medicine and Science, College of MedicineResidency, Internal Medicine, 2004 - 2007
- Iran University of Medical SciencesClass of 2000
Certifications & Licensure
- CA State Medical License 2006 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2013
Clinical Trials
- A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 65 citationsA new combination of testosterone and nestorone transdermal gels for male hormonal contraceptionNiloufar Ilani, Mara Y. Roth, John K. Amory, Ronald S. Swerdloff, Clint Dart
The Journal of Clinical Endocrinology and Metabolism. 2012-07-12 - 49 citationsAcceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trialMara Y. Roth, Grace Shih, Niloufar Ilani, Christina Wang, Stephanie T. Page
Contraception. 2014-10-01 - 24 citationsCharacteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gelsMara Y. Roth, Niloufar Ilani, Christina Wang, Stephanie T. Page, William J. Bremner
Andrology. 2013-11-01
Professional Memberships
- Member